Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Burkitt lymphoma - abrahem
#1
A 6-year-old child from Zimbabwe is admitted to a U.S. oncology center for treatment of an advanced case of Burkitt lymphoma. Analysis of the malignant cells reveals that they are lacking MHC class I antigens on their surface. Which of the following cytokines pro­duced by recombinant DNA technology could be injected into his solid tumor to increase this tumor cell's susceptibility to CD8+-mediated killing?
(A) IFN-y
(B) IL-1
© IL-2
(D) IL-10
(E) TNF-cc
Reply
#2
A??
Reply
#3
its TNF alfa but since there isn no option so i go for E
Reply
#4
e is TNF-alpa
Reply
#5
ok...tx
Reply
#6
the correct answer not E but i just typed E for it written wrong
Reply
#7
sso wats the corect ans if its not e
Reply
#8
the correct answer is A
Reply
#9
any explanation pls??
TNF alfa inc MHC1expression n G-interferon i thot inhibits MHC1 expression
Reply
#10
go to kaplan notes page 470
Reply
« Next Oldest | Next Newest »


Forum Jump: